Novartis Bioventures is a global venture capital firm that invests in products such as medical therapeutics and platforms. Sectors in which it invests include medical devices and implants, diagnostics and biomarkers research, and drug delivery and polymers. As of 2020, it has approximately $800 million under management with more than 24 portfolio companies. It has made nearly 200 investments in total and has had 51 exits. Between 1998 and 2009, Novartis Bioventures raised three funds totaling more than $720 million.
Dr. Anja König
Dr. Laura Brass
Xconomy: Intellikine Attracts Novartis, Biogen, and Others for $51M Second Round
July 9, 2009